ArticleBlood advances2024
Jian Y, Chang L, Shi M-X, et al. Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood Adv. 2023;7(24):7581-7584.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.